<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Vinall, Phil</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Díaz, José F.</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">The Role and Importance of Plaque Modification Devices in Coronary Angioplasty</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2011</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2011-09-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">29-30</style></pages><abstract><style  face="normal" font="default" size="100%">Although data indicate that plaque modification does not have a direct influence on target lesion restenosis, it improves stent expansion and makes otherwise impossible cases possible. This article provides an overview of the need for devices to pretreat complex lesions with PM.</style></abstract><number><style face="normal" font="default" size="100%">6</style></number><volume><style face="normal" font="default" size="100%">11</style></volume></record></records></xml>